This could support semiautomated abstraction, but given the potential risk for harm, human review would be essential before using results for any patient engagement or care decisions. Furthermore, ...

Security doesn't fail at the point of breach. It fails at the point of impact. That line set the tone for this year's Picus Breach and Simulation (BAS) Summit, where researchers, practitioners, and ...

Abstract: This paper investigates the system design and experimental validation of integrated sensing and communication (ISAC) for environmental sensing, which is expected to be a critical enabler for ...

Comparative studies demonstrate that patients who use electronic patient-reported outcomes (ePROs) experience better outcomes; however, research comparing ePRO designs to determine optimal strategies ...

Plus, how to gently tell your boss you have a better way of doing things. Credit...Margeaux Walter for The New York Times Supported by By Rachel Dry Send questions about the office, money, careers and ...

The C# Excel Library · Intuitive C# & VB.NET Excel API · No need to install MS Office or Excel Interop ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression using JavaScript. Linear regression is the simplest machine learning technique to predict a single numeric value, ...

Are your web privacy controls protecting your users, or just a box-ticking exercise? This CISO's guide provides a practical roadmap for continuous web privacy validation that's aligned with real-world ...

What if the next big startup idea isn’t born in a brainstorming session but crafted through a seamless blend of human intuition and AI precision? Imagine a world ...

1 School of Psychology, Liverpool John Moores University, Liverpool, United Kingdom 2 School of Psychology, Manchester Metropolitan University, Manchester, United Kingdom The Illusory Health Beliefs ...

Objective: This study aimed to perform a comprehensive evaluation on the extent generative models can be used to simulate additional patients to compensate for insufficient accrual in clinical trials.